Which program provides unapproved drugs to qualified AIDS patients?

• A. Labeled Indications
• B. Treatment INDs
• C. Black Box Warnings
• D. Post-Market Surveillance

Answer: (B)

The main idea is how seriously ill patients can access investigational therapies before they’re approved. For AIDS patients who have no satisfactory alternatives, there’s a Treatment IND program that lets doctors obtain unapproved drugs that are still being studied. This pathway is designed to provide potential options while maintaining safety oversight—the sponsor must supply the drug, the FDA reviews the request, and appropriate monitoring and consent are required. This isn’t about drugs that are already approved for a labeled use, nor about safety warnings on approved drugs, nor about monitoring safety after approval. It’s specifically for access to investigational, not-yet-approved therapies for a life-threatening condition.